Follistatin is known to neutralize signaling by ______. FST’s antioxidant effect is lost if it is ______. Hypertension is defined by sustained blood pressure above ____ mmHg. "In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______. FST lowers ROS levels, as indicated by a decrease in ______ levels. What assay did we use to quantify hydrogen peroxide? _____________ Which normotensive strain served as our control? _____________ What does the abbreviation 'SHR' stand for? _____________ Neutralizing antibodies targeted activin A and ______. Follistatin treatment reduced blood pressure by approximately ______ mmHg. Follistatin must maintain its proper ______ to be functional. Our assay directly measures hydrogen ______ levels. Follistatin retains its antioxidant effect even when denatured. True/False Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric? _____________ Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function. In our study, follistatin was administered to SHRs over a period of ______ weeks. The fluorescent product produced in the AmplexRed assay is called ______. Follistatin increases the expression of ______, which is critical for nitric oxide production. Which protein marker indicates a brown adipose phenotype in PVAT? _____________ What is the endogenous protein we studied that antagonizes activin? _____________ Which hypertensive animal model did we use? ___________ Our study shows that blocking activin signaling reduces ______ production. FST was administered every ______ day. Enhanced NO bioavailability indicates improved ______. Follistatin is known to neutralize signaling by ______. FST’s antioxidant effect is lost if it is ______. Hypertension is defined by sustained blood pressure above ____ mmHg. "In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______. FST lowers ROS levels, as indicated by a decrease in ______ levels. What assay did we use to quantify hydrogen peroxide? _____________ Which normotensive strain served as our control? _____________ What does the abbreviation 'SHR' stand for? _____________ Neutralizing antibodies targeted activin A and ______. Follistatin treatment reduced blood pressure by approximately ______ mmHg. Follistatin must maintain its proper ______ to be functional. Our assay directly measures hydrogen ______ levels. Follistatin retains its antioxidant effect even when denatured. True/False Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric? _____________ Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function. In our study, follistatin was administered to SHRs over a period of ______ weeks. The fluorescent product produced in the AmplexRed assay is called ______. Follistatin increases the expression of ______, which is critical for nitric oxide production. Which protein marker indicates a brown adipose phenotype in PVAT? _____________ What is the endogenous protein we studied that antagonizes activin? _____________ Which hypertensive animal model did we use? ___________ Our study shows that blocking activin signaling reduces ______ production. FST was administered every ______ day. Enhanced NO bioavailability indicates improved ______.
(Print)
Follistatin is known to neutralize signaling by ______.
FST’s antioxidant effect is lost if it is ______.
Hypertension is defined by sustained blood pressure above ____ mmHg.
"In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______.
FST lowers ROS levels, as indicated by a decrease in ______ levels.
What assay did we use to quantify hydrogen peroxide?
_____________
Which normotensive strain served as our control?
_____________
What does the abbreviation 'SHR' stand for?
_____________
Neutralizing antibodies targeted activin A and ______.
Follistatin treatment reduced blood pressure by approximately ______ mmHg.
Follistatin must maintain its proper ______ to be functional.
Our assay directly measures hydrogen ______ levels.
Follistatin retains its antioxidant effect even when denatured.
True/False
Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric?
_____________
Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function.
In our study, follistatin was administered to SHRs over a period of ______ weeks.
The fluorescent product produced in the AmplexRed assay is called ______.
Follistatin increases the expression of ______, which is critical for nitric oxide production.
Which protein marker indicates a brown adipose phenotype in PVAT?
_____________
What is the endogenous protein we studied that antagonizes activin?
_____________
Which hypertensive animal model did we use?
___________
Our study shows that blocking activin signaling reduces ______ production.
FST was administered every ______ day.
Enhanced NO bioavailability indicates improved ______.
